Literature DB >> 1534017

Inflammatory reactions in primary osteoarthritis of the hip and total hip prosthesis loosening.

B Greitemann1, B Mues, J Polster, T Pauly, C Sorg.   

Abstract

In 14 patients [9 with loosened total hip arthroplasty (THA), 5 with primary osteoarthritis], the inflammatory cell infiltrate was characterized in cryostat tissue sections using antibodies against subsets of macrophages and lymphocytes. In all patients the abundance of a mature type macrophage (25F9+) was observed, whereas 27E10+ macrophages, characteristic of acute inflammatory reactions, were not seen in primary osteoarthritis but were found in 4 out of 9 patients with THA loosening. The RM3/1 + macrophage phenotype was seen in some of both sets of patients (osteoarthritis 4/5; THA loosening 4/9). The markers MRP8 and MRP14 typical of immature macrophages, were found in all patients with osteoarthritis and in some (4/9 and 8/9 respectively) of those with THA loosening. IOT4+ T-helper cells were only present in 1/5 5 patients with osteoarthritis and in 2/9 patients with THA loosening. IOT8+ T-suppressor lymphocytes were more frequently present (in 4/5 and 5/9 respectively). The data reveal remarkable differences between the two groups of patients. While the inflammatory infiltrate in patients with osteoarthritis lacks the characteristics of acute inflammation, in patients THA loosening the inflammatory process seems to be determined by periods of acute reactions. The occasional presence particularly of T-helper cells suggests that the inflammatory process is less T-cell but rather macrophage-driven.

Entities:  

Mesh:

Year:  1992        PMID: 1534017     DOI: 10.1007/bf00388087

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  25 in total

1.  Phenotypic dynamics of macrophage subpopulations during human experimental gingivitis.

Authors:  H H Topoll; G Zwadlo; D E Lange; C Sorg
Journal:  J Periodontal Res       Date:  1989-03       Impact factor: 4.419

2.  Reactivity of monoclonal anti-type II collagen antibodies with cartilage and synovial tissue in rheumatoid arthritis and osteoarthritis.

Authors:  L Klareskog; O Johnell; A Hulth; R Holmdahl; K Rubin
Journal:  Arthritis Rheum       Date:  1986-06

3.  Biochemical and histological changes in osteoarthritic synovial membrane.

Authors:  O Gedikoglu; M T Bayliss; S Y Ali; I Tuncer
Journal:  Ann Rheum Dis       Date:  1986-04       Impact factor: 19.103

4.  [Clinical, radiological and histological investigations in loosened total hip replacements (author's transl)].

Authors:  K E Brinkmann; K Heilmann
Journal:  Arch Orthop Unfallchir       Date:  1974

5.  Reaction of bone to methacrylate after hip arthroplasty: a long-term gross, light microscopic, and scanning electron microscopic study.

Authors:  H G Willert; J Ludwig; M Semlitsch
Journal:  J Bone Joint Surg Am       Date:  1974-10       Impact factor: 5.284

6.  [The reaction of bone to bone-cement in the replacement of the hip joint].

Authors:  H G Willert; P Puls
Journal:  Arch Orthop Unfallchir       Date:  1972

7.  A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes.

Authors:  G Zwadlo; E B Bröcker; D B von Bassewitz; U Feige; C Sorg
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

8.  Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues.

Authors:  G Zwadlo; J Brüggen; G Gerhards; R Schlegel; C Sorg
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

9.  The production and biology of polyethylene wear debris.

Authors:  P A Revell; B Weightman; M A Freeman; B V Roberts
Journal:  Arch Orthop Trauma Surg       Date:  1978-05-30

10.  A rat model of resorption of bone at the cement-bone interface in the presence of polyethylene wear particles.

Authors:  D W Howie; B Vernon-Roberts; R Oakeshott; B Manthey
Journal:  J Bone Joint Surg Am       Date:  1988-02       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.